SCHEMBL5705575

SCHEMBL5705575

Oc1ccc(-c2c3ccccc3c(-c3ccc(O)cc3)c3ccccc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 8/20 0.57
▸ ESR2 Q92731 6/20 0.57
▸ MMP3 P08254 1/20 0.57
▸ BCL2L1 Q07817 1/20 0.57
▸ SENP1 Q9P0U3 1/20 0.48
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ PTPN1 P18031 3/20 0.46
▸ PDE4A P27815 1/20 0.45
▸ PDE4B Q07343 1/20 0.45
▸ PDE4C Q08493 1/20 0.45
▸ PDE4D Q08499 1/20 0.45
▸ CA12 O43570 2/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA3 P07451 2/20 0.45
▸ CA4 P22748 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ CA14 Q9ULX7 2/20 0.45
▸ GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30692092 1.00 ESR1 (0.57) ESR1ESR2MMP3BCL2L1SENP1
SCHEMBL16000739 0.97 MMP3 (0.62) ESR1ESR2MMP3BCL2L1SENP1
SCHEMBL27979824 0.95 MMP3 (0.67) ESR1ESR2MMP3BCL2L1MEN1
SCHEMBL30633884 0.95 MMP3 (0.67) ESR1ESR2MMP3BCL2L1MEN1
SCHEMBL13825919 0.93 MMP3 (0.71) ESR1ESR2MMP3BCL2L1MEN1
SCHEMBL27951333 0.92 ESR1 (0.55) ESR1ESR2MMP3BCL2L1SENP1
SCHEMBL20323058 0.85 ESR1 (0.64) ESR1ESR2MMP3BCL2L1MEN1
SCHEMBL4349120 0.85 MMP3 (0.61) ESR1ESR2MMP3BCL2L1SENP1
SCHEMBL20323049 0.85 ESR1 (0.61) ESR1ESR2MMP3BCL2L1MEN1
SCHEMBL13059867 0.85 MMP3 (0.61) ESR1ESR2MMP3BCL2L1SENP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2024-02-15 — — US disclosed
US-20230340194-A1 RESIN, RESIN PRECURSOR COMPOSITION, COATING COMPOSITION, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, MOLDED ARTICLE, ELECTRONIC DEVICE, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR PRODUCTION METHOD IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-26 — — US disclosed
EP-4130097-A1 RESIN, RESIN PRECURSOR COMPOSITION, COATING COMPOSITION, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, MOLDED ARTICLE, ELECTRONIC DEVICE, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR PRODUCTION METHOD Idemitsu Kosan Co., Ltd (JP) 2023-02-08 — — EP disclosed
US-10875983-B2 Photon upconversion film and method for producing the same WAKAYAMA PREFECTURE (JP) 2020-12-29 — — US disclosed
US-20200270419-A1 PHOTON UPCONVERSION FILM AND METHOD FOR PRODUCING THE SAME WAKAYAMA PREFECTURE (JP) 2020-08-27 — — US disclosed
EP-2695930-B1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE, NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE DAINIPPON INK & CHEMICALS (JP) 2019-09-11 — — EP disclosed
US-9475991-B2 Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative ADEKA CORPORATION (JP) 2016-10-25 — — US disclosed
US-9475991-B2 Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative ADEKA CORPORATION (JP) 2016-10-25 — — US disclosed
US-9475991-B2 Polymerizable liquid crystal composition, polarized light-emitting coating material, novel naphtholactam derivative novel coumarin derivative, novel nile red derivative, and novel anthracene derivative ADEKA CORPORATION (JP) 2016-10-25 — — US disclosed
EP-2695930-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE, NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE Adeka Corporation (JP) 2014-02-12 — — EP disclosed
US-20130334461-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE ADEKA CORPORATION (JP) 2013-12-19 — — US disclosed
US-20130334461-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE ADEKA CORPORATION (JP) 2013-12-19 — — US disclosed
US-20130334461-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLARIZED LIGHT-EMITTING COATING MATERIAL, NOVEL NAPHTHOLACTAM DERIVATIVE NOVEL COUMARIN DERIVATIVE, NOVEL NILE RED DERIVATIVE, AND NOVEL ANTHRACENE DERIVATIVE ADEKA CORPORATION (JP) 2013-12-19 — — US disclosed
EP-1054933-B1 CHEMILUMINESCENT REACTIONS USING DIHYDROXYAROMATIC COMPOUNDS AND HETEROCYCLIC ENOL PHOSPHATES LUMIGEN INC (US) 2006-09-06 — — EP disclosed
US-6824949-B2 SELF-CONDENSATION OF AN O-AMINOPHENOLCARBOXYLIC ACID AND REACTION WITH BIS-O-AMINOPHENOLS ALONG WITH DICARBOXYLIC ACID AND ACETYLENE COMPOUNDS; HIGH RESISTANCE AGAINST THE DIFFUSION OF METALS INFINEON TECHNOLOGIES AG (DE) 2004-11-30 — — US disclosed
EP-1189974-B1 POLYBENZOXAZOLE PRECURSORS INFINEON TECHNOLOGIES AG (DE) 2003-05-21 — — EP disclosed
US-6531632-B2 Reacting dihydroxy compound with halogenated o-nitrophenol INFINEON TECHNOLOGIES AG (DE) 2003-03-11 — — US disclosed
US-20020086968-A1 Polybenzoxazole precursors, photoresist solution, polybenzoxazole, and process for preparing a polybenzoxazole precursor POLARIS INNOVATIONS LIMITED (IE) 2002-07-04 — — US disclosed
US-20020010370-A1 Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same POLARIS INNOVATIONS LIMITED (IE) 2002-01-24 — — US disclosed
EP-1132374-A2 Bis-o-aminophenols and o-aminophenolcarboxylic acids Infineon Technologies AG (DE) 2001-09-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010370-A1 Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same FOS, POF1B, FOSB ESR1 234/4885ESR2 685/4885MMP3 3396/4885
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TERT, TERB1, MCM5 ESR1 3620/4885ESR2 2848/4885MMP3 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback